This SuperSeries is composed of the SubSeries listed below.
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.
Sex, Age, Specimen part, Disease
View SamplesGenome-wide transcriptome analysis of expression changes in Globus Pallidus interna (GPi) from Parkinson's disease brain tissue versus control brain tissue.
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.
Sex, Specimen part, Disease, Disease stage
View SamplesGenome-wide transcriptome analysis of expression changes in laser-dissected SNpc neurons from Parkinson's disease brain tissue versus control brain tissue.
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.
Specimen part, Disease, Disease stage
View SamplesSystematic meta-analysis and replication of genome-wide expression studies identifies molecular pathways of Parkinson's disease.
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.
Age, Specimen part, Disease
View SamplesGenome-wide transcriptome analysis of expression changes in EBV transformed cell lines from the Coriell Cell Repository in Parkinson and Control subjects.
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.
Sex, Disease, Disease stage
View SamplesSystematic meta-analysis and replication of genome-wide expression studies identifies molecular pathways of Parkinson's disease.
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.
Sex, Age, Specimen part, Disease
View SamplesAnalysis of substantia nigra from postmortem brains of 4 patients with Parkinsons disease (PD). Results provide insight into the molecular processes perturbed in the PD substantia nigra.
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.
Sex, Age, Specimen part, Disease
View SamplesIn order to identify genes that are activated in differentiating WT ESCs, but are missing in Tal-1-/- and Runx1-/- ESCs, and which might be involved in the generation of definitive hematopoietic progenitors and their specification thereafter, we performed microarray analyses on purified Flk-1+ cells, differentiated from these ESCs for 4, 5, and 6 days in vitro.
Ectopic Runx1 expression rescues Tal-1-deficiency in the generation of primitive and definitive hematopoiesis.
Specimen part, Cell line, Time
View SamplesRecent data from our group, demonstrate that infusion of myelin oligodendrocyte glycoprotein (MOG35-55) peptide, leads to induction of MOG35-55-specific Tregs and subsequent suppression of Experimental Autoimmune Encephalomyelitis (EAE), the mouse model of multiple sclerosis. Amelioration of EAE was accompanied by reduced MOG-specific Th1 and Th17 responses in the draining lymph nodes (dLNs). Phenotypic analysis of the dLNs of MOG-infused mice revealed a significant Treg-mediated reduction in the recruitment of 7AAD-CD3-CD19-CD11c+CD11bhighGr-1+ iDCs compared to non-infused control immunized mice. Focusing on the delineation of novel molecules/genes that are involved in the MOG-specific Treg-mediated suppression of autoimmune responses, we have isolated highly purified iDCs from MOG infused and non-infused control immunized mice.
De novo-induced self-antigen-specific Foxp3+ regulatory T cells impair the accumulation of inflammatory dendritic cells in draining lymph nodes.
Sex, Specimen part
View SamplesPreB cells were analyzed for differences in gene expression before and after the overexpression of miR-221. In order to dissect possible targets for the miR-221, gene expression profiles of preB cells un-induced or induced for the miR-221 expression after 8, 16 and 24 hours were compared. All induction time-points, e.g. after 8, 16 and 24 hours were compared to un-induced preB cells and to each other group.
SiPaGene: A new repository for instant online retrieval, sharing and meta-analyses of GeneChip expression data.
Specimen part
View Samples